About infexn® — NGS-Based Infection Diagnostics by HaystackAnalytics
infexn® is India's most advanced NGS-based infectious disease diagnostic test — detecting bacteria, fungi, viruses and antibiotic resistance genes from a single sample in 24 hours.
infexn® is India's leading NGS-based infection diagnostic test, developed by HaystackAnalytics Private Limited — a genomics healthtech company specializing in next-generation sequencing based clinical solutions. Originally incubated at IIT Bombay, we are driving innovation that enables hospitals, diagnostic labs, and clinicians to deliver rapid and precise infection diagnostics. Our patented technologies, including Universal ID™ CE-IVD and Ω ID™, are transforming clinical practice, improving patient outcomes, and shaping the future of genomic healthcare.
At infexn®, we are not just advancing diagnostics — we are giving clinicians the genomic tools to identify infections faster, treat smarter and combat antimicrobial resistance across India.
Making genomics
Accessible
Applicable
Affordable
The Growing Challenge of Infectious Diseases & Antimicrobial Resistance
Rising Infection Deaths
Infectious diseases cause over 13 million deaths annually worldwide. Rapid and accurate pathogen detection is critical to reducing preventable deaths. — WHO 2024
Rise of Antimicrobial Resistance (AMR)
AMR directly caused 1.27 million deaths globally in 2019. NGS-based diagnostics like infexn® enable targeted therapy and reduce unnecessary antibiotic use. — WHO 2024
Evolving Disease Epidemiology
Climate change is expanding the geographic range of vector-borne diseases globally, demanding faster and more comprehensive infection diagnostic solutions. — WHO 2024
Meet the Founding Team Behind infexn® NGS
 | Dr. Anirvan ChatterjeeCo-founder & CEO HaystackAnalytics Pvt. Ltd. Dr. Anirvan Chatterjee is a genomics scientist and entrepreneur with over 15 years of experience at the intersection of infectious diseases, genomics, and public health innovation. During his time at the University of Oxford, he contributed to building one of the world’s earliest population-scale clinical genomics solutions and was among the pioneers advancing Whole Genome Sequencing (WGS) for tuberculosis diagnostics and treatment optimization. |
Gaurav SrivastavaCo-founder & COO HaystackAnalytics Pvt. Ltd. Gaurav Srivastava is an alumnus of IIT Kharagpur and an experienced entrepreneur with deep expertise in building and scaling technology-led businesses. He began his entrepreneurial journey in 2012 with Scrollback, an open-source community chat platform launched in Singapore, where he pioneered scalable digital engagement solutions. |  |
 | Prof. Kiran KondabagilCo-founder & CSM HaystackAnalytics Pvt. Ltd. Prof. Kiran Kondabagil is a distinguished scientist working at the convergence of virology, genomics, and infectious disease biology. As a Professor in the Department of Biosciences and Bioengineering at IIT Bombay, he brings decades of academic excellence and translational research experience to the field of genomic science. |
infexn® Scientific Advisory Board — Leading Medical Experts
Dr. Aruna Poojary
Dr. Arunaloke Chakraborti
Dr. Pallab Ray
Dr. S K Todi